The Greatest Way To Set Your Organization Up For Economical Good results
Irrespective of whether you are running a facet hustle, began a new company, or are in your business's expansion stage,...
Irrespective of whether you are running a facet hustle, began a new company, or are in your business's expansion stage,...
WARRINGTON, Pa., March 29, 2021 /PRNewswire/ -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on...
GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)--Mar 29, 2021--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company...
OMAHA, Neb.--(BUSINESS WIRE)--Mar 29, 2021--Boston Omaha Corporation (NASDAQ: BOMN) (the “Company”) announced its financial results for the fiscal year ended...
BloombergBig Oil’s Secret World of Trading(Bloomberg Markets) -- It was a bleak moment for the oil industry. U.S. shale companies...
Total revenue of $233 million1 in 2020, up 1,908% year-over-yearTotal revenue from research fees of $20 million, up 71% year-over-yearTotal...
Reported a revenue of approximately USD 390 million, a 42.9% YoY increase, and a gross profit of USD 260 million,...
MONTREAL, March 26, 2021 (GLOBE NEWSWIRE) -- (TSX-V: FRO.UN) Fronsac Real Estate Investment Trust (“Fronsac”) announces a business update, monthly...
BEIJING, March 26, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases,...
Major expansion of clinical portfolio including initiation of clinical trials with Tedopi® in ovarian cancer, OSE-127/S95011 in ulcerative colitis, FR104...
MINNEAPOLIS, March 25, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics...
MARLBOROUGH, Mass., March 25, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of...
PALO ALTO, Calif., March 25, 2021 /PRNewswire/ -- Inpixon (Nasdaq: INPX), the Indoor Intelligence™ company, today provided a business update...
- Completed $25 Million Strategic Financing; Extending Cash Runway into 2023- Accelerated Development of AL102 Desmoid Tumor Program into Phase...
Immunocore Provides Business Update and Reports Full Year 2020 Financial Results Breakthrough Therapy Designation granted by the FDA for tebentafusp...
Q4 2020 Net Revenue $20.6 Million, Highest Net Revenue Quarter Since Launch of Jeuveau®Pro Forma Cash Position of $57 Million...
No safety concerns or evidence of Graft-versus-Host disease reported from first dose cohort of Phase 1 dose-escalation IMMUNICY-1 trial for...
TipRanksPotent Insider Acquiring Could Show a Base in These 2 StocksJust about every trader is aware of that the path...